AUREOMYCIN AND ITS EFFECT IN EARLY STAGES OF SYPHILIS

Publisher Website
Google Scholar
Abstract
Aureomycin, one of the newer antibiotics first described by Duggar,1 has been shown to be active against certain viruses and rickettsia,2 gram-positive and gram-negative micro-organisms,3 and to be even more effective than penicillin in experimental spirochetal infections, namely: relapsing fever (Borrelia novyi) and spirochetal jaundice, or Weil's disease (Leptospira icterohemorrhagiae).4 This last-mentioned observation by Heilman prompted O'Leary, Kierland and Herrell5 to investigate the effect of aureomycin on Treponema pallidum in man. It was concluded on the basis of a study in 2 patients with syphilis in an early stage that "aureomycin appears to have some anti-spirochetal activity when administered by the oral route." On March 1, 1949 a study was initiated at the Chicago Intensive Treatment Center concerning aureomycin and its effect in early infectious dark fieldpositive syphilis. Twenty-seven patients had been treated by May 5, 1949. All patients in the study had dark field-positive

This publication has 1 reference indexed in Scilit: